Archive for March 2017
ANDA Applications Could Hit New Record in Fiscal 2017
Fiscal 2017 could be a record-setting year for ANDA applications if trends continue. Source: Drug Industry Daily
Read MoreFDA Warns Singapore Drugmaker Over Validation, Labeling Issues
The FDA hit drugmaker Opto-Pharm with a warning letter, citing a lack of written procedures for preventing contamination of sterile drug products, as well as problems with validation, testing and labeling. Source: Drug Industry Daily
Read MoreFDA Accepts Novartis, Kite Pharma’s Personalized Cancer Treatments for Review
The FDA has accepted for review the first two novel, personalized cancer treatments — known as chimeric antigen receptor T-cell therapies, or CAR-T — using immune system cells drawn from the blood and reprogrammed to target cancer cells. Source: Drug Industry Daily
Read MoreGAO Asks State Pharmacy Regulators to Rate Interactions with the FDA
More than a dozen state pharmacy regulatory authorities told the GAO they have trouble communicating with the FDA on drug compounding issues. Source: Drug Industry Daily
Read MoreLivaNova PLC CFO Resigns
Life Sciences Jobs … Source: BioSpace
Read MoreRepros Therapeutics Reports Fourth Quarter And Year End 2016 Financial Results
Life Sciences Jobs … Source: BioSpace
Read MoreAkers Biosciences Announces A $2 Million Private Placement
Life Sciences Jobs … Source: BioSpace
Read MoreProlacta Bioscience Names New Members And Expands Resources For Dietitians And Clinicians
Life Sciences Jobs … Source: BioSpace
Read MoreQIAGEN N.V. Joins CANCER-ID Consortium For Liquid Biopsy Workflows
Life Sciences Jobs … Source: BioSpace
Read MoreNovartis AG's Talent Woes Continue as Seattle Genetics Poaches a Top CAR-T Exec
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815×450-seattle-genetics.jpg" NAME"Novartis AG's Talent Woes Continue as Seattle Genetics Poaches a Top CAR-T Exec" ALT"Novartis AG's Talent Woes Continue as Seattle Genetics Poaches a Top CAR-T Exec"March 31, 2017By Mark Terry… Source: BioSpace
Read More